Old and new antirheumatic drugs for the treatment of COVID-19

Joint Bone Spine. 2020 May;87(3):195-197. doi: 10.1016/j.jbspin.2020.03.013.
No abstract available

Keywords: B-DMARDs; Covid-19; DMARDs; Ts-DMARDs.

Publication types

  • Editorial

MeSH terms

  • Angiotensin-Converting Enzyme 2
  • Antirheumatic Agents / therapeutic use*
  • Betacoronavirus / immunology
  • Betacoronavirus / pathogenicity*
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / immunology
  • Cytokines* / metabolism
  • Humans
  • Pandemics
  • Peptidyl-Dipeptidase A
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / immunology
  • SARS-CoV-2

Substances

  • Antirheumatic Agents
  • Cytokines
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2

Supplementary concepts

  • COVID-19 drug treatment

Associated data

  • ClinicalTrials.gov/NCT04320277